Q1 2026 BIO-Key International Inc Earnings Call Transcript
Key Points
- BIO-key International Inc (BKYI) reported a 34% increase in Q1 2026 revenues to $2.1 million, driven by new customer wins and expanded deployments.
- The company has a strong gross margin of 82%, benefiting from high-margin license fee revenue and sales of fully reserved inventory.
- BIO-key's partnership with DLT Solutions, a division of TD SYNNEX, provides a streamlined procurement path for public sector customers, enhancing market reach.
- The company is seeing significant traction in defense and financial services, with several prominent defense organizations as customers.
- BIO-key's business model is predominantly subscription-based with recurring revenues, providing a scalable and efficient growth strategy.
- BIO-key's shares were recently suspended from NASDAQ, and while an appeal is in process, the outcome and timing remain uncertain.
- The company reported a net loss of $165,036 in Q1 2026, although this was an improvement from the previous year's loss.
- There are challenges in the U.S. market due to privacy concerns and regulatory scenarios, which do not exist in international markets.
- Hardware revenue, while increased, is more volatile and can be lumpy compared to the steadier license revenue.
- The company faces competition from large biometric players and regional competitors, although it differentiates itself with a comprehensive authentication platform.
Good morning, everyone.
Thank you for standing by, and welcome to the BIO-Key's International first quarter 2026 conference call. (operator instructions) I would now like to turn the call over to Mr. Bill Jones of Investor Relations. You may proceed.
Thank you, Chuck.
Hosting today are BIO-Key's Chairman and CEO, Mike DePasquale, and its CFO, C.C. Welch.
(event instructions)
Now, I'll turn the call over to Mike to begin.
Thanks, Bill, and thanks to everyone for joining us today.
After my remarks, CC will review the financials and we'll open up the call to investor questions.
Our Q1 26 results and Q2 26 outlook reflect the benefit of our team's hard work, particularly over the last year.
We're also seeing expanded appreciation for the unparalleled value that our biometric identity and access management solutions provide in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
